William Gradishar Selected Research

Icrucumab

1/2017

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William Gradishar Research Topics

Disease

44	Breast Neoplasms (Breast Cancer) 11/2023 - 06/2005
21	Neoplasms (Cancer) 01/2023 - 06/2005
5	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2007
4	Triple Negative Breast Neoplasms 01/2023 - 06/2015
4	Fatigue 08/2022 - 01/2020
3	Pain (Aches) 08/2022 - 04/2015
3	Exanthema (Rash) 01/2020 - 01/2013
3	Disease Progression 01/2018 - 05/2007
2	Central Nervous System Diseases (CNS Diseases) 06/2023 - 01/2020
2	Pathologic Complete Response 01/2023 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2021
1	COVID-19 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Constipation 07/2021
1	Cytopenia 01/2020
1	Diarrhea 01/2020
1	Liver Failure 01/2020
1	Hand-Foot Syndrome 01/2020
1	Hemorrhage 01/2018
1	Proteinuria 01/2018
1	Obesity 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2016
1	Body Weight (Weight, Body) 09/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013
1	Digestive System Diseases 01/2013
1	Metabolic Bone Diseases (Osteopenia) 02/2011
1	Hip Fractures (Intertrochanteric Fractures) 02/2011
1	Osteoporosis 02/2011

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 01/2023 - 06/2005
7	Aromatase InhibitorsIBA 06/2023 - 06/2005
7	human ERBB2 proteinIBA 01/2023 - 09/2009
6	Estrogen ReceptorsIBA 01/2023 - 06/2005
6	Lapatinib (GW572016)FDA Link 01/2021 - 04/2012
5	Fulvestrant (Faslodex)FDA Link 01/2023 - 06/2005
5	Capecitabine (Xeloda)FDA Link 01/2021 - 09/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2015
3	exemestane (Aromasin)FDA Link 10/2020 - 04/2008
3	AnthracyclinesIBA 01/2018 - 09/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2011
3	taxaneIBA 01/2018 - 02/2008
3	Trastuzumab (Herceptin)FDA Link 03/2016 - 01/2013
3	130-nm albumin-bound paclitaxelIBA 04/2012 - 02/2010
3	Tamoxifen FDA LinkGeneric 02/2011 - 06/2005
2	palbociclibIBA 06/2023 - 01/2023
2	Circulating Tumor DNAIBA 01/2022 - 01/2017
2	neratinibIBA 01/2021 - 01/2020
2	Phenobarbital (Luminal)FDA Link 03/2020 - 09/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 09/2009
2	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 02/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 02/2011
2	Docetaxel (Taxotere)FDA Link 10/2011 - 02/2010
1	Cyclin D1IBA 06/2023
1	tucatinibIBA 06/2023
1	Letrozole (Femara)FDA LinkGeneric 06/2023
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	RNA (Ribonucleic Acid)IBA 03/2020
1	pembrolizumabIBA 01/2020
1	telapristone acetateIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 10/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	enzalutamideIBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2017
1	IcrucumabIBA 01/2017
1	RamucirumabIBA 01/2017
1	eribulin FDA Link 06/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 06/2015
1	Pemetrexed (MTA)FDA Link 04/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2013
1	Phosphotransferases (Kinase)IBA 04/2012
1	SolventsIBA 10/2011
1	Albumin-Bound Paclitaxel FDA Link 10/2011
1	ixabepilone (BMS 247550)FDA Link 09/2009
1	Epidermal Growth Factor (EGF)IBA 09/2009
1	Epothilones (Epothilone)IBA 09/2009
1	epothilone B (EPO906)IBA 09/2009
1	BilirubinIBA 05/2007
1	YttriumIBA 05/2007

Therapy/Procedure

21	Therapeutics 06/2023 - 06/2005
12	Drug Therapy (Chemotherapy) 08/2022 - 09/2009
5	Adjuvant Chemotherapy 03/2020 - 01/2013
3	Neoadjuvant Therapy 11/2023 - 06/2015
2	Activities of Daily Living (ADL) 08/2022 - 12/2020
1	Radiotherapy 01/2021
1	Diet Therapy (Therapy, Diet) 01/2018
1	Brachytherapy 05/2007
1	Aftercare (After-Treatment) 05/2007